Homocysteine, folic acid and vitamin B12 serum levels in hemodialysis patients referring to hemodialysis unit of Jahrom hospitalSotoodeh Jahromi A1,2, Farjam MR*3, Shojaei M4Received: 09/25/2010Revised: 01/27/2011Accepted: 01/29/20111. Dept. of Immunology, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran2. Research Center for Zoonotic Diseases, Jahrom University of Medical Sciences, Jahrom, Iran 3. Dept. of Biochemistry, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran4. Dept. of Internal Medicine, School of Medicine, Jahrom University of Medical Sciences, Jahrom, IranJournal of Jahrom University of Medical Sciences, Vol. 9, No. 1, Spring 2011 ...
Hyperhomocysteinemia in hemodialysis patients: Effects of 12-month supplementation with hydrosoluble...
Plasma homocysteine (tHcy) is an important risk factor for atherosclerosis in dialysis patients. Few...
Objective: To evaluate the determinants of total plasma homocysteine levels and their relations with...
Background: Folic acid (FA) and vitamin B12 treatment have been routinely prescribed to lower serum ...
BACKGROUND: Plasma homocysteine (Hcy) is an independent risk factor for cardiovascular disease. High...
Introduction: Deficiencies of water soluble vitamins such as folate and vitamin B12 has been reporte...
Background: In subjects with renal disease, levels of homocysteine are raised leading to its excreti...
Aim: Results from several studies indicate that the total homocysteine (tHcy) concentration in plasm...
INTRODUCTION: Hyperhomocysteinemia is one of the causes of the increased incidence of cardiovascular...
Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.Backgrou...
Background. Treatment with folic acid and Vitamin B12 appears to be effective to reduce total plasma...
Background: Hyperhomocysteinemia is a common metabolic abnormality in patients undergoing hemodialys...
Background. Treatment with folic acid and Vitamin B12 appears to be effective to reduce total plasma...
grantor: University of TorontoHyperhomocysteinemia and cardiovascular disease are prevalen...
grantor: University of TorontoHyperhomocysteinemia and cardiovascular disease are prevalen...
Hyperhomocysteinemia in hemodialysis patients: Effects of 12-month supplementation with hydrosoluble...
Plasma homocysteine (tHcy) is an important risk factor for atherosclerosis in dialysis patients. Few...
Objective: To evaluate the determinants of total plasma homocysteine levels and their relations with...
Background: Folic acid (FA) and vitamin B12 treatment have been routinely prescribed to lower serum ...
BACKGROUND: Plasma homocysteine (Hcy) is an independent risk factor for cardiovascular disease. High...
Introduction: Deficiencies of water soluble vitamins such as folate and vitamin B12 has been reporte...
Background: In subjects with renal disease, levels of homocysteine are raised leading to its excreti...
Aim: Results from several studies indicate that the total homocysteine (tHcy) concentration in plasm...
INTRODUCTION: Hyperhomocysteinemia is one of the causes of the increased incidence of cardiovascular...
Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.Backgrou...
Background. Treatment with folic acid and Vitamin B12 appears to be effective to reduce total plasma...
Background: Hyperhomocysteinemia is a common metabolic abnormality in patients undergoing hemodialys...
Background. Treatment with folic acid and Vitamin B12 appears to be effective to reduce total plasma...
grantor: University of TorontoHyperhomocysteinemia and cardiovascular disease are prevalen...
grantor: University of TorontoHyperhomocysteinemia and cardiovascular disease are prevalen...
Hyperhomocysteinemia in hemodialysis patients: Effects of 12-month supplementation with hydrosoluble...
Plasma homocysteine (tHcy) is an important risk factor for atherosclerosis in dialysis patients. Few...
Objective: To evaluate the determinants of total plasma homocysteine levels and their relations with...